Corrigendum to “Antibody neutralization of retargeted measles viruses”[Virology 454-455 (2014) 237-246]

PJ Lech, R Pappoe, T Nakamura, SJ Russell - Virology, 2014 - core.ac.uk
PJ Lech, R Pappoe, T Nakamura, SJ Russell
Virology, 2014core.ac.uk
These authors played a role in the design of selected mutations within H82 glycoprotein.
Hence we would like to acknowledge this by stating that: SJR, PLN, PJL & GJT conceived
and designed the H82 glycoprotein with masked epitopes. New authorship is as follows:
Patrycja J. Lecha, n, Roland Pappoea, b, Takafumi Nakamurac, Gregory J. Tobind, Peter L.
Narad Stephen J. Russella aDepartment of Molecular Medicine, Mayo Clinic, Rochester,
MN, USA bBuena Vista University, Storm lake, IA, USA cDepartment of Biomedical …
These authors played a role in the design of selected mutations within H82 glycoprotein. Hence we would like to acknowledge this by stating that: SJR, PLN, PJL & GJT conceived and designed the H82 glycoprotein with masked epitopes. New authorship is as follows: Patrycja J. Lecha, n, Roland Pappoea, b, Takafumi Nakamurac, Gregory J. Tobind, Peter L. Narad Stephen J. Russella aDepartment of Molecular Medicine, Mayo Clinic, Rochester, MN, USA bBuena Vista University, Storm lake, IA, USA cDepartment of Biomedical Sciences, Tottori University, Japan dBiological Mimetics, Inc., Frederick, MD, USA The authors would also like to add the following to the acknowledgements:“We would like to acknowledge Ruth Bushnell and John K. Tobin for testing if selected mutations in H82 glycoproteins interfered with the ability of H to induce cell–cell fusion when co-expressed with the fusion glycoprotein in cultured cells.” The authors would like to apologise for any inconvenience caused.
core.ac.uk